• Epidemiology and risk stratification in healthy and sick population

• Expanding the target population for anti-platelet/coagulation therapy

• Controversial issues: from clinical studies to real life

• Sport and cardiac pathologies

• Nuclear cardiology in CAD and CHF patients

Acute Coronary Syndromes

• Evolving therapies for Acute myocardial Infarction: when PTCA, when stent?

• Hybrid myocardial revascularization

• Post-ACS patient’s route

• Anti-thrombotic therapy in STEMI and NSTEMI patient

• Management of STEMI and non-STEMI patient

• New antiplatelet drugs

• BioResorbable Vascular Scaffold update in interventional cardiology

• Spinal Cord Stimulation in refractory CAD: still an appropriate choice?

• Chronic Ischemic artery disease: dignaostic pathways and therapeutical algorythms

Global Cardiovascular Risk Prevention

• Global Cardiovascular Risk assessment and prevention

• Insulin Resistance Syndrome, type 2 Diabetes and Atherosclerosis: an explosive mixture

• Lipid-lowering therapy: do we need statins for all life long?

• Diagnosis and treatment of patients with hypercholesterolemia : update

• New drugs for treating resistant hypercholesterolemia

• PCSK9i and clinical outcomes

• Role of platelets in the atherosclerosis pathogenesis

• Drug interaction, gender, age and comorbidities

• Elderly and Cardiology: are all patients to be treated the same way?

• Right pharmacological therapy in fragile patient

Echocardiography & Imaging

• Echocardiography in the evaluation of the induced AF-mechanical remodelling

• Evaluation of thromboembolic atrial sources

• Echo optimisation of atrial-ventricular delay in paced AF patients

• Doppler echocardiography in the management of the resynchronization in HF

• Consensus Documents on Imaging and coronary anatomy

Heart Failure

• The interaction of AF and CHF and its clinical implications

• Neurohumoral activation in CHF patients

• Latest pharmacological therapy for CHF

• The HF doctor: is there still a role for clinical cardiologists?

• What lessons from the early completed trials?

• Management of hypertrophic and dilated cardiomyopathy

• Biomarkers in HF

• Management and diagnostic pathways for HF ambulatory network

Non-Invasive Risk Stratification

• New non-invasive markers for risk stratification

Syncope

• Syncope: practical issues of diagnosis and treatment

• Physical treatment of neurally-mediated syncope

• Organizational models of Syncope Unit

• Modern management of chest pain and unexplained palpitations

• The new generation implantable loop recorders

Hypertrophic Cardiomyopathy

• ...

New Guidelines in Cardiology

• ...